MLchartDataset catalogue

Autologous tumor infiltrating lymphocytes LM103

Term · Oncology and biomedicine · MLC-T-ONC-011794

A preparation of autologous tumor infiltrating lymphocytes (TILs) derived from each patient's resected tumor and expanded ex vivo, with potential immunomodulating and antineoplastic activities. Upon administration back into the patient, the autologous TILs LM103 specifically recognize and kill the patient's tumor cells.

Table 1. Record
IdentifierMLC-T-ONC-011794
FieldOncology and biomedicine
Synonymsautologous TILs LM103
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-011794",
  "term": "Autologous tumor infiltrating lymphocytes LM103",
  "field": "Oncology and biomedicine",
  "definition": "A preparation of autologous tumor infiltrating lymphocytes (TILs) derived from each patient's resected tumor and expanded ex vivo, with potential immunomodulating and antineoplastic activities. Upon administration back into the patient, the autologous TILs LM103 specifically recognize and kill the patient's tumor cells.",
  "synonyms": [
    "autologous TILs LM103"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/autologous-tumor-infiltrating-lymphocytes-lm103/"
}

Record 3,132 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.